Recent News
2019 | 2018 | 2017 | 2016 | 2015 | 2014
11-11-19 ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019
11-05-19 ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019
08-29-19 ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
08-12-19 ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
08-06-19 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
05-13-19 ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
05-07-19 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
03-29-19 ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
03-27-19 ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
03-26-19 ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
02-13-19 ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
02-06-19 ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018